Robert Torray - Torray Fund Investment Strategy & Portfolio Analysis
How Torray Fund allocates capital, manages risk, and constructs its portfolio — based on SEC 13F filings.
As of Mar 31, 2026, Robert Torray's Torray Fund portfolio reflects a quant / systematic investor approach across 86 reported 13F positions. Portfolio returns are distributed across holdings, with the top five positions representing approximately 23% of total exposure. Across 86 reported holdings, economic exposure is broadly distributed across technology, financials, and healthcare without dominant single-name concentration. Exposure to high-growth and technology-oriented segments is elevated relative to peers, with performance instead anchored in durable, cash-generating businesses across financials, healthcare, and energy. The portfolio exhibits low turnover, consistent with a buy-and-hold posture held through multiple reporting cycles. Distinctive traits include Long-Term Holder, Broadly Diversified, Economically Diversified.
Investment Style
Value, growth, quality, and behavioral classification from latest 13F holdings.
Primary type: Quant / Systematic Investor
Traits: Long-Term Holder, Broadly Diversified, Economically Diversified, Structurally Diversified
Turnover profile
Moderate
Holding horizon
Long-Term
Portfolio Construction
Concentration and position sizing in the latest filing.
Portfolio construction is lowly concentrated: top three names represent 14.2% of assets, top five 22.6%, and the largest single position is 4.8%.
Top 3 weight
14.2%
Top 5 weight
22.6%
Top 10 weight
40.5%
Largest position
4.8%
Top holdings: Royalty Pharma, Broadcom Inc., Microsoft Corporation, Chevron Corporation, Constellation Energy Corporatio — view full holdings
Sector Preferences
Where capital is allocated by sector.
Capital is tilted toward Technology and Financial Services, with 12 sectors represented in the latest filing.
Leading sectors: Technology, Financial Services, Healthcare
Risk Framework
Concentration, diversification, and turnover tolerance.
This investor accepts low single-name risk (largest position 4.8%, top ten 40.5%) and high economic diversification (HHI 0.02). Turnover tolerance maps to a moderate profile.
Largest position
4.8%
Top 10 weight
40.5%
Max sector
21.7%
Diversification
High
Strategy Evolution
How the strategy changed between the two most recent filing periods.
Dec 31, 2025 → Mar 31, 2026
- Position count decreased from 93 to 86 (-7 names).
- Top-five concentration rose from 20.7% to 22.6%.
- Largest holding changed from Broadcom Inc. to Royalty Pharma.
- Quarter-over-quarter portfolio weight turnover: 14.0%.
For trade-level changes, see the Activity page. View activity.
Similar Investors
Peer group with comparable portfolio behavior.
Similar-investor comparisons are coming soon.